{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-002335","form_type":"8-K/A","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.834770+00:00","generated_at":"2026-05-18T09:09:22.714143+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Silexion amends 8-K, delays Nasdaq transfer; reverse split expected in August to cure bid price deficiency","bullets":["Nasdaq transfer to Capital Market not on July 8 as originally reported; now expected as soon as practicable.","Shareholder vote on 1-for-15 reverse split reconvenes July 14, 2025 at annual meeting.","After approval, 10-day Nasdaq notice period ends ~July 25; then 10 consecutive trading days above $1.00 needed.","Compliance with minimum bid price rule expected early to mid-August; no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-002335","json":"https://secwatch.observer/filing/0001178913-25-002335.json","markdown":"https://secwatch.observer/filing/0001178913-25-002335.md","text":"https://secwatch.observer/filing/0001178913-25-002335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002335/0001178913-25-002335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002335/zk2533427.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:09:22.714143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}